Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’
Pharma giant ditches £1bn London research hub and says UK ‘is not internationally competitive’ … from the Independent Karl Matchett
